{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:00:41Z","timestamp":1791968441658,"version":"4.3.4"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ypmed.2018.12.021","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T12:30:16Z","timestamp":1545913816000},"page":"108-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8216-7098","authenticated-orcid":false,"given":"N.J.","family":"Polman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.F.","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.G.","family":"Kenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.L.M.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2018.12.021_bb0005","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","article-title":"Trends of cervical cancer mortality in the member states of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European guidelines for quality Assurance in Cervical Cancer Screening. Second edition\u2013summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","article-title":"Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis","volume":"15","author":"Arbyn","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0025","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/ijc.22484","article-title":"Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs","volume":"120","author":"Bais","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0030","first-page":"1105","article-title":"Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997\u20132012","volume":"26","author":"Baldur-Felskov","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0035","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/ijc.26202","article-title":"Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing","volume":"130","author":"Belinson","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju423","article-title":"Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial","volume":"107","author":"Bergeron","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cncy.21542","article-title":"Prospective evaluation of p16\/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results","volume":"123","author":"Bergeron","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0050","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/ijc.25211","article-title":"The health and economic effects of HPV DNA screening in the Netherlands","volume":"127","author":"Berkhof","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0055","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/ijc.28138","article-title":"CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease","volume":"133","author":"Bierkens","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0060","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/ijc.22114","article-title":"Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands","volume":"119","author":"Bos","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ypmed.2014.04.011","article-title":"Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women","volume":"64","author":"Bosgraaf","year":"2014","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ijc.29026","article-title":"Comparative performance of novel self-sampling methods in detecting high-risk human papillomavirus in 30,130 women not attending cervical screening","volume":"136","author":"Bosgraaf","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0075","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0080","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjc.6603653","article-title":"High-risk HPV type-specific clearance rates in cervical screening","volume":"96","author":"Bulkmans","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0085","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/0284186X.2011.555779","article-title":"European guidelines for quality assurance in cervical histopathology","volume":"50","author":"Bulten","year":"2011","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0090","series-title":"Risk Assessment to Guide the Prevention of Cervical Cancer","first-page":"1","volume":"12","author":"Castle","year":"2008"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0095","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25\u202fyears and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0100","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1200\/JCO.2011.38.8389","article-title":"Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18\u202fyears of follow-up","volume":"30","author":"Castle","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1309\/AJCP4Q0NSDHWIZGU","article-title":"Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population","volume":"143","author":"Castle","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12885-015-1306-x","article-title":"The end of the decline in cervical cancer mortality in Spain: trends across the period 1981-2012","volume":"15","author":"Cervantes-Amat","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0115","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and north American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/LGT.0b013e31825c31dd","article-title":"The lower Anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology","volume":"16","author":"Darragh","year":"2012","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0125","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/ijc.25553","article-title":"Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached?","volume":"128","author":"de Kok","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0130","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1136\/bmj.e670","article-title":"Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model","volume":"344","author":"de Kok","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0135","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1158\/1055-9965.EPI-14-0347","article-title":"Combined CADM1\/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women","volume":"23","author":"De Strooper","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0140","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/1940-6207.CAPR-14-0237","article-title":"Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2\/3 lesions","volume":"7","author":"De Strooper","year":"2014","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-13-0173","article-title":"Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy","volume":"23","author":"Dijkstra","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0150","first-page":"355","article-title":"Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14\u202fyear follow-up of population based randomised cohort in the Netherlands","volume":"i4924","author":"Dijkstra","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0155","series-title":"Cervical Screening (In Dutch)","author":"Dutch Health Council","year":"2011"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0160","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/modpathol.2017.16","article-title":"Evaluation of p16\/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women","volume":"30","author":"Ebisch","year":"2017","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0165","doi-asserted-by":"crossref","first-page":"g130","DOI":"10.1136\/bmj.g130","article-title":"Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial","volume":"348","author":"Elfstrom","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0170","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.bjc.6606040","article-title":"The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)","volume":"104","author":"Giorgi Rossi","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0175","doi-asserted-by":"crossref","first-page":"c1040","DOI":"10.1136\/bmj.c1040","article-title":"HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study","volume":"340","author":"Gok","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0180","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/ijc.26128","article-title":"Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program","volume":"130","author":"Gok","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/v9100267","article-title":"Natural history of HPV infection across the lifespan: role of viral latency","volume":"9","author":"Gravitt","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jviromet.2012.11.010","article-title":"Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens","volume":"189","author":"Guan","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0195","first-page":"1590","article-title":"The population-based screening for cervical cancer. A uniform framework for cytopathological diagnosis (In Dutch)","volume":"50","author":"Hanselaar","year":"1995","journal-title":"Medisch Contact"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0200","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ijc.28723","article-title":"Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy","volume":"135","author":"Hesselink","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0205","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/jnci\/djt235","article-title":"Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study","volume":"105","author":"Ikenberg","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0210","series-title":"In WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. Geneva","year":"2013"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2303.2008.00623.x","article-title":"European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1","volume":"19","author":"Jordan","year":"2008","journal-title":"Cytopathology"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0220","series-title":"Blaustein's Pathology of the Female Genital Tract","author":"K","year":"2010"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0225","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12885-016-2246-9","article-title":"Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device","volume":"16","author":"Karjalainen","year":"2016","journal-title":"BMC Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.ypmed.2018.12.021_bb0230","first-page":"S3\/63","article-title":"Chapter 7: achievements and limitations of cervical cytology screening","volume":"24","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0235","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"Kitchener","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0240","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejca.2011.01.008","article-title":"A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial","volume":"47","author":"Kitchener","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0245","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/bjc.2016.290","article-title":"Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study","volume":"115","author":"Landy","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0250","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/modpathol.2016.80","article-title":"p16\/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population","volume":"29","author":"Luttmer","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0255","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.29824","article-title":"Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16\/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study)","volume":"138","author":"Luttmer","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0260","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0265","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0270","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrclinonc.2012.161","article-title":"Screening: Cervical cancer--should we abandon cytology for screening?","volume":"9","author":"Meijer","year":"2012","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0275","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0280","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.5858\/arpa.2012-0115-CP","article-title":"The Tahoe study: bias in the interpretation of Papanicolaou test results when human papillomavirus status is known","volume":"138","author":"Moriarty","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.ypmed.2018.12.021_bb0285","first-page":"S3\/1","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Munoz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0290","series-title":"Effects of the New Cervical Screening Programme in the Netherlands Following Recent Developments (In Dutch)","author":"Naber","year":"2016"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0295","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0300","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0305","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"101","author":"Naucler","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0310","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/IGC.0b013e318280f3bc","article-title":"Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection","volume":"23","author":"Nieves","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0315","series-title":"Guideline CIN, AIS and VAIN (in Dutch)","author":"Oncoline: Guidelines Oncological Care","year":"2015"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0320","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ijc.25890","article-title":"Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women","volume":"129","author":"Overmeer","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0325","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.95.2469.438","article-title":"A new procedure for staining vaginal smears","volume":"95","author":"Papanicolaou","year":"1942","journal-title":"Science"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0330","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer epidemic that screening has prevented in the UK","volume":"364","author":"Peto","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0335","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","article-title":"Triaging pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 dual-stained cytology","volume":"121","author":"Petry","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ypmed.2018.12.021_bb0340","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jcv.2015.10.023","article-title":"Commercially available molecular tests for human papillomaviruses (HPV): 2015 update","volume":"76","author":"Poljak","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0345","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/bjc.2017.309","article-title":"HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test","volume":"117","author":"Polman","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0350","article-title":"Clinical performance of HPV testing on self-collected versus clinician-collected samples: results of a randomised paired screen-positive non-inferiority trial","author":"Polman","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0355","article-title":"Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands","author":"Polman","year":"2018","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0360","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":"A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China","volume":"9","author":"Qiao","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0365","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/cncy.21596","article-title":"HPV DNA testing with cytology triage in cervical cancer screening: influence of revealing HPV infection status","volume":"123","author":"Richardson","year":"2015","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0370","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.bjc.6605869","article-title":"Comparison of hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test","volume":"103","author":"Rijkaart","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0375","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0380","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0385","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/bjc.2011.581","article-title":"HPV DNA testing in population-based cervical screening (VUSA-screen study): results and implications","volume":"106","author":"Rijkaart","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0390","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0395","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejca.2016.09.008","article-title":"Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms","volume":"68","author":"Ronco","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0400","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.bjc.6600974","article-title":"Benefit of cervical screening at different ages: evidence from the UK audit of screening histories","volume":"89","author":"Sasieni","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0405","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0410","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cncy.20140","article-title":"p16\/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study","volume":"119","author":"Schmidt","year":"2011","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0415","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jnci\/95.1.46","article-title":"Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis","volume":"95","author":"Sherman","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0420","first-page":"1393","article-title":"Impact of the National Cervical Screening Programme in New Zealand by age: analysis of cervical cancer trends 1985\u20132013 in all women and in Maori women","volume":"28","author":"Smith","year":"2017","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0425","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/ijc.27790","article-title":"High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening","volume":"132","author":"Snijders","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0430","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0435","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0440","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Atypical squamous cells of undetermined significance-low-grade squamous intraepithelial lesion triage study G. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study","volume":"285","author":"Stoler","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0445","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1186\/s12885-015-1804-x","article-title":"Women's experience with home-based self-sampling for human papillomavirus testing","volume":"15","author":"Sultana","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0450","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1258\/096914107780154486","article-title":"Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting","volume":"14","author":"Szarewski","year":"2007","journal-title":"J. Med. Screen."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0455","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/bjc.2011.48","article-title":"HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial","volume":"104","author":"Szarewski","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0460","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1158\/1940-6207.CAPR-14-0409","article-title":"Five-year cervical (pre)Cancer risk of women screened by HPV and cytology testing","volume":"8","author":"Uijterwaal","year":"2015","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0465","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1097\/PAS.0000000000000498","article-title":"Investigating diagnostic problems of CIN1 and CIN2 associated with high-risk HPV by combining the novel molecular biomarker PanHPVE4 with P16INK4a","volume":"39","author":"van Baars","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0470","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/ijc.23276","article-title":"Mass screening programmes and trends in cervical cancer in Finland and the Netherlands","volume":"122","author":"van der Aa","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0475","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1471-0528.2011.03228.x","article-title":"Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing","volume":"119","author":"van Rosmalen","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0480","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/jclinpath-2018-205271","article-title":"Three-tiered score for Ki-67 and p16(ink4a) improves accuracy and reproducibility of grading CIN lesions","volume":"71","author":"van Zummeren","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0490","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","article-title":"Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial","volume":"15","author":"Verhoef","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0495","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2014.08.003","article-title":"Methylation marker analysis and HPV16\/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer","volume":"135","author":"Verhoef","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0500","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/aje\/kwt077","article-title":"Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data","volume":"178","author":"Vink","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0505","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1002\/ijc.25581","article-title":"Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland","volume":"128","author":"Virtanen","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0510","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2014.09.019","article-title":"Self-sampling experiences among non-attendees to cervical screening","volume":"135","author":"Virtanen","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0515","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pvr.2015.06.006","article-title":"European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination","volume":"1","author":"von Karsa","year":"2015","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0520","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0525","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-12-0270","article-title":"Performance of p16\/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population","volume":"18","author":"Wentzensen","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0530","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv257","article-title":"p16\/Ki-67 dual stain cytology for detection of cervical precancer in HPV-positive women","volume":"107","author":"Wentzensen","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0535","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/ijc.30579","article-title":"Eurogin 2016 roadmap: how HPV knowledge is changing screening practice","volume":"140","author":"Wentzensen","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2018.12.021_bb0540","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0545","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygyno.2016.10.031","article-title":"Triaging HPV-positive women with p16\/Ki-67 dual-stained cytology: results from a sub-study nested into the ATHENA trial","volume":"144","author":"Wright","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0550","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnci\/djr532","article-title":"Pooled analysis of a self-sampling HPV DNA test as a cervical cancer primary screening method","volume":"104","author":"Zhao","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2018.12.021_bb0555","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat. Rev. Cancer"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743518304006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743518304006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:01:50Z","timestamp":1758794510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743518304006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":110,"alternative-id":["S0091743518304006"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2018.12.021","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2018.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}